|
|
|
Volumn 83, Issue 3, 2012, Pages 241-244
|
|
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CLOFAZIMINE;
DAPSONE;
LEPROSTATIC AGENT;
MINOCYCLINE;
OFLOXACIN;
RIFAMPICIN;
DRUG ADMINISTRATION;
DRUG COMBINATION;
DRUG EFFECT;
EDITORIAL;
HUMAN;
LEPROSY;
MYCOBACTERIUM LEPRAE;
PATIENT COMPLIANCE;
WORLD HEALTH ORGANIZATION;
CLOFAZIMINE;
DAPSONE;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
HUMANS;
LEPROSTATIC AGENTS;
LEPROSY;
MINOCYCLINE;
MYCOBACTERIUM LEPRAE;
OFLOXACIN;
PATIENT COMPLIANCE;
RIFAMPIN;
WORLD HEALTH ORGANIZATION;
|
|
EID: 84873261948
PISSN: 03057518
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (6)
|
|
References (0)
|
